Adverse Reactions and Attitudes Toward the BNT162b2 COVID-19 Vaccine in Children 5 to 11 Years of Age in Japan

Detalles Bibliográficos
Autores principales: Matsumoto, Naomi, Shimizu, Junya, Yokoyama, Yuji, Tsukahara, Hirokazu, Yorifuji, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Epidemiological Association 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794448/
https://www.ncbi.nlm.nih.gov/pubmed/36310061
http://dx.doi.org/10.2188/jea.JE20220265
_version_ 1784860037533925376
author Matsumoto, Naomi
Shimizu, Junya
Yokoyama, Yuji
Tsukahara, Hirokazu
Yorifuji, Takashi
author_facet Matsumoto, Naomi
Shimizu, Junya
Yokoyama, Yuji
Tsukahara, Hirokazu
Yorifuji, Takashi
author_sort Matsumoto, Naomi
collection PubMed
description
format Online
Article
Text
id pubmed-9794448
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Japan Epidemiological Association
record_format MEDLINE/PubMed
spelling pubmed-97944482023-02-06 Adverse Reactions and Attitudes Toward the BNT162b2 COVID-19 Vaccine in Children 5 to 11 Years of Age in Japan Matsumoto, Naomi Shimizu, Junya Yokoyama, Yuji Tsukahara, Hirokazu Yorifuji, Takashi J Epidemiol Letter to the Editor Japan Epidemiological Association 2023-02-05 /pmc/articles/PMC9794448/ /pubmed/36310061 http://dx.doi.org/10.2188/jea.JE20220265 Text en © 2022 Naomi Matsumoto et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Letter to the Editor
Matsumoto, Naomi
Shimizu, Junya
Yokoyama, Yuji
Tsukahara, Hirokazu
Yorifuji, Takashi
Adverse Reactions and Attitudes Toward the BNT162b2 COVID-19 Vaccine in Children 5 to 11 Years of Age in Japan
title Adverse Reactions and Attitudes Toward the BNT162b2 COVID-19 Vaccine in Children 5 to 11 Years of Age in Japan
title_full Adverse Reactions and Attitudes Toward the BNT162b2 COVID-19 Vaccine in Children 5 to 11 Years of Age in Japan
title_fullStr Adverse Reactions and Attitudes Toward the BNT162b2 COVID-19 Vaccine in Children 5 to 11 Years of Age in Japan
title_full_unstemmed Adverse Reactions and Attitudes Toward the BNT162b2 COVID-19 Vaccine in Children 5 to 11 Years of Age in Japan
title_short Adverse Reactions and Attitudes Toward the BNT162b2 COVID-19 Vaccine in Children 5 to 11 Years of Age in Japan
title_sort adverse reactions and attitudes toward the bnt162b2 covid-19 vaccine in children 5 to 11 years of age in japan
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794448/
https://www.ncbi.nlm.nih.gov/pubmed/36310061
http://dx.doi.org/10.2188/jea.JE20220265
work_keys_str_mv AT matsumotonaomi adversereactionsandattitudestowardthebnt162b2covid19vaccineinchildren5to11yearsofageinjapan
AT shimizujunya adversereactionsandattitudestowardthebnt162b2covid19vaccineinchildren5to11yearsofageinjapan
AT yokoyamayuji adversereactionsandattitudestowardthebnt162b2covid19vaccineinchildren5to11yearsofageinjapan
AT tsukaharahirokazu adversereactionsandattitudestowardthebnt162b2covid19vaccineinchildren5to11yearsofageinjapan
AT yorifujitakashi adversereactionsandattitudestowardthebnt162b2covid19vaccineinchildren5to11yearsofageinjapan

Ejemplares similares